Newsroom
Sorted by: Latest
-
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that data from an investigator-initiated Phase II trial conducted at Memorial Sloan Kettering Cancer Center will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22, 2026, in San Diego, CA. The study evaluates botensilimab (BOT) and balstilimab (BAL) in combination with agenT-797, an allogeneic iNKT cell therapy developed...
-
Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – GOSS
LOS ANGELES--(BUSINESS WIRE)--Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – GOSS...
-
XCharge North America and JOJO Superfast EV Charging Launch New Midwest EV Charging Infrastructure
KYLE, Texas--(BUSINESS WIRE)--XCharge North America ("XCharge NA"), the North American subsidiary of XCHG Limited (Nasdaq: XCH) and a provider of high-power EV charging and battery-integrated solutions designed to strengthen the North American electrical grid, and JOJO Superfast EV Charging today announced a strategic partnership to deploy a high-power electric vehicle charging network across Illinois. Beyond manufacturing the chargers, XCharge NA will oversee every site from concept to complet...
-
Andersen Consulting tilføjer Multiplica
SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting indgår en samarbejdsaftale med Multiplica, et digitalt konsulentfirma, der hjælper organisationer med at designe, bygge og skalere effektfulde digitale oplevelser. Multiplica, der er stiftet i Spanien og desuden har aktiviteter i Latinamerika og USA, fokuserer på brugerundersøgelser og behovsafdækning, research af kundeoplevelser, digital strategi, datamodellering og -analyse, rapportautomatisering og datavisualisering, konverteringsoptimering...
-
Stündenglass x Be$os Partnership Signals New Era of Latino Culture-Driven Cannabis Branding
LOS ANGELES--(BUSINESS WIRE)--Be$os, a Latino-rooted cannabis lifestyle brand, has partnered with Stündenglass, an industry leader in gravity-powered infusion technology, to launch a special-edition, Talavera-inspired gravity infuser. This marks one of Stündenglass’ first collaborations with a Latino-focused brand—and marks a new chapter for Be$os, which officially launched in summer of 2025 with a line of all-in-ones and pre-rolls. More than a high-end product drop, the collaboration represent...
-
Lindsay Corporation Announces Quarterly Cash Dividend
OMAHA, Neb.--(BUSINESS WIRE)--Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.37 per share, payable May 29, 2026, to shareholders of record at the close of business on May 15, 2026. As of April 1, 2026, Lindsay Corporation had approximately 10.4 million shares outstanding, which are traded on the New York Stock...
-
Banc of California Announces Schedule of First Quarter 2026 Earnings Release and Conference Call
LOS ANGELES--(BUSINESS WIRE)--Banc of California, Inc. (the “Company”) (NYSE: BANC) today announced it will release financial results for the first quarter ended March 31, 2026 after market close on Wednesday, April 22, 2026. The Company will host a conference call to discuss these financial results the following day on Thursday, April 23, 2026, at 10:00 a.m. Pacific Time (PT). Interested parties are welcome to attend the conference call by dialing (888) 317-6003 and referencing event code 5670...
-
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2026
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 2. Identi...
-
Tikehau Capital : Déclaration des transactions sur actions propres réalisées du 27 mars 2026 au 02 avril 2026
PARIS--(BUSINESS WIRE)--Regulatory News: Conformément à l’article 5 du Règlement européen n° 596/2014 (Règlement MAR – Market Abuse Regulation), les informations détaillées sont disponibles sur le site de Tikehau Capital (Paris:TKO) : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondéré moyen jou...
-
Tikehau Capital: Disclosure of Shares Repurchases from 27 March 2026 to 02 April 2026
PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with Article 5 of EU Regulation n° 596/2014 (Market Abuse Regulation), detailed information is available on the website of Tikehau Capital (Paris:TKO): https://www.tikehaucapital.com/fr/shareholders/regulatory-information Name of the issuer Issuer Identity Code (LEI) Trading Day ISIN Aggregated volume per day (number of shares) Weighted average price per day Market (MIC Code) TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 27/03/2026 FR0013230612 3 71...